Kunming Longjin Pharmaceutical Co Ltd (002750) — Capital Reinvestment Ratio
Kunming Longjin Pharmaceutical Co Ltd (002750) has a Capital Reinvestment Ratio of 6.23x as of December 2022, meaning it reinvests 6% of its operating cash flow (CN¥867.54K) in capital expenditures (CN¥5.41 Million). See 002750 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kunming Longjin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2019)
This chart tracks Kunming Longjin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Kunming Longjin Pharmaceutical Co Ltd (2011–2019)
Year-by-year Capital Reinvestment Ratio for Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2019. For live market cap and broader valuation context, see how much is Kunming Longjin Pharmaceutical Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 1.75x | CN¥4.04 Million | CN¥7.07 Million | ▲ +257.1% |
| 2018 | 0.49x | CN¥31.70 Million | CN¥15.53 Million | ▲ +62.2% |
| 2017 | 0.30x | CN¥58.06 Million | CN¥17.54 Million | ▲ +33.7% |
| 2016 | 0.23x | CN¥104.24 Million | CN¥23.56 Million | ▼ -33.7% |
| 2015 | 0.34x | CN¥70.19 Million | CN¥23.93 Million | ▲ +29.5% |
| 2014 | 0.26x | CN¥70.16 Million | CN¥18.47 Million | ▼ -52.9% |
| 2013 | 0.56x | CN¥106.46 Million | CN¥59.57 Million | ▼ -31.2% |
| 2012 | 0.81x | CN¥91.16 Million | CN¥74.14 Million | ▼ -33.5% |
| 2011 | 1.22x | CN¥75.90 Million | CN¥92.79 Million | — |